✦ LIBER ✦

1157 Modified Release Phosphatidylcholine LT-02 in Active Ulcerative Colitis - a Randomized, Placebo-Controlled Multicentre Study

✍ Scribed by Max Karner; Andreas Kocjan; Jürgen Stein; Georg von Boyen; Peter Uebel; Carsten Schmidt; Limas Kupcinskas; Ion Dina; Anja Hanemann; Frank Zuelch; Gerhard Keilhauer; Wolfgang Stremmel

Book ID: 119433633
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 72 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(12)60790-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Placebo-Controlled, Phase

A Randomized, Placebo-Controlled, Phase II Study of Tetomilast in Active Ulcerative Colitis

✍ Stefan Schreiber; Ali Keshavarzian; Kim L. Isaacs; John Schollenberger; Juan P. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Clinical trial: a multicentre, randomize

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

✍ C. PENA-ROSSI; S. SCHREIBER; G. GOLUBOVIC; A. MERTZ-NIELSEN; J. PANES; D. RACHMI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

SUPPLEMENTATION WITH THE PROBIOTIC VSL#3

SUPPLEMENTATION WITH THE PROBIOTIC VSL#3 IN PATIENTS WITH MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY

✍ A. Tursi; A. Papa; G. Brandimarte; A. Giglio; W. Elisei; G.M. Giorgetti; G. Fort 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

388 Supplementation with the Probiotic V

388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study

✍ Antonio Tursi; Giovanni Brandimarte; Alfredo Papa; Andrea Giglio; Walter Elisei; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

46 A Phase 2a Randomized Placebo-Control

46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis

✍ Severine Vermeire; Paul J. Rutgeerts; Geert R. D'Haens; Martine De Vos; Brian Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB